Sfoglia per Autore  

Opzioni
Mostrati risultati da 101 a 150 di 227
Titolo Data di pubblicazione Autore(i) File
Outcome of allogeneic stem cell transplantation following reduced-intensity conditioninig regimen in patients with idiopathic myelofibrosis: the G.I.T.M.O. Experience. 1-gen-2010 Patriarca, Francesca; Bacigalupo, A; Sperotto, A; Isola, Miriam; Bruno, B; van Lint, Mt; Iori, Ap; Di Bartolomeo, P; Musso, M; Pioltelli, P; Visani, G; Iacopino, P; Fanin, Renato; Bosi, A.
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction before, and consolidation after, double autologous stem cell transplantation in newly diagnosed multiple myeloma: a randomized phase 3 study. 1-gen-2010 Cavo, M; Tacchetti, P; Patriarca, Francesca; Petrucci, Mt; Pantani, L; Galli, M; Di Raimondo, F; Crippa, C; Zamagni, E; Palumbo, A; Offidani, M; Corradini, P; Narni, F; Spadano, A; Pescosta, N; Lambertenghi Deliliers, G; Ledda, A; Cellini, C; Caravita, T; Tosi, P; Baccarani, M; GIMEMA Italian Myeloma, Network
Pretransplantation 18F-Fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-hodgkin lymphoma undergoing reduced-intensity conditioning follone by allogeneic stem cell transplantation 1-gen-2010 Dodero, A; Crocchiolo, R; Patriarca, Francesca; Miceli, R; Castagna, L; Ciceri, F; Bramanti, S; Frungillo, N; Milani, R; Crippa, F; Fallanca, F; Englaro, E; Corradini, P.
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients. 1-gen-2010 Palumbo, A; Gay, F; Falco, P; Crippa, C; Montefusco, V; Patriarca, Francesca; Rossini, F; Caltagirone, S; Benevolo, G; Pescosta, N; Guglielmelli, T; Bringhen, S; Offidani, M; Giuliani, N; Petrucci, Mt; Musto, P; Liberati, Am; Rossi, G; Corradini, P; Boccadoro, M.
The burden of multiple myeloma: Assessment on occurrence, outcomes and cost using a retrospective longitudinal study based on administrative claims database 1-gen-2011 de Portu, S.; Fanin, R.; Patriarca, F.; Morsanutto, A.; Tosolini, F.; Esti, R.; Mantovani, L. G.
Safety and efficacy of bortezomib-melphalan-prednisone-talidomide followed by bortezomib-thalidomide maintenance ( VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment 1-gen-2011 Morabito, F; Gentile, M; Mazzone, C; Rossi, D; Di Raimondo, F; Bringhen, S; Ria, R; Offidani, M; Patriarca, Francesca; Nozzoli, C; Petrucci, Mt; Benevolo, G; Vincelli, I; Guglielmelli, T; Grasso, M; Marasca, R; Baldini, L; Montefusco, V; Musto, P; Cascavilla, N; Majolino, I; Musolino, C; Cavo, M; Boccadoro, M; Palumbo, A.
Stem cell mobilization in patients wuth newly diagnosed multiple myeloma after lenalidomide induction therapy 1-gen-2011 Cavallo, F; Bringhen, S; Millone, G; Ben yehuda, D; Nagler, A; Calabrese, E; Cascavilla, N; Montefusco, V; Lupo, B; Liberati, Am; Crippa, C; Rossini, F; Passera, R; Patriarca, Francesca; Cafro, Am; Omedè, P; Carella, Am; Peccatori, J; Catalano, L; Caravita, T; Musto, P; Petrucci, Mt; Boccadoro, M; Palumbo, A.
Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant 1-gen-2011 Zaja, Francesco; Geromin, A; Patriarca, Francesca; Puglisi, S; Cerno, M; Sperotto, A; Battista, Ml; Isola, Miriam; Fanin, Renato
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey in 50 patients 1-gen-2011 Gozzetti, A; Cerase, A; Lotti, F; Rossi, D; Palumbo, A; Petrucci, Mt; Patriarca, Francesca; Nozzoli, C; Cavo, M; Offidani, M; Floridia, M; Berretta, S; Vallone, R; Musto, P; Lauria F., for the GIMEMA Myeloma Working Party
Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant 1-gen-2011 Spina, F; Montefusco, V; Crippa, C; Citro, A; Sanmassimo, S; Olivero, B; Gentili, S; Galli, M; Guglielmelli, T; Rossi, D; Falcone, Ap; Grasso, M; Patriarca, Francesca; De Muro, M; Corradini, P.
Aspirin, warfarin or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label randomized trial 1-gen-2011 Palumbo, A; Cavo, M; Bringhen, S; Zamagni, E; Romano, A; Patriarca, Francesca; Rossi, D; Gentilini, F; Crippa, C; Galli, M; Nozzoli, C; Ria, R; Marasca, R; Montefusco, V; Baldini, L; Elice, F; Callea, V; Pulini, S; Carella, Am; Zambello, R; Benevolo, G; Magarotto, V; Tacchetti, P; Pescosta, N; Cellini, C; Polloni, C; Evangelista, A; Caravita, T; Morabito, F; Offidani, M; Tosi, P; Boccadoro, M.
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients 1-gen-2011 Gay, F; Larocca, A; Wijermans, P; Cavallo, F; ., Rossi D; Schaafsma, R; Genuardi, M; Romano, A; Liberati, Am; Siniscalchi, A; Petrucci, Mt; Nozzoli, C; Patriarca, Francesca; Offidani, M; Ria, R; Omedè, P; Bruno, B; Passera, R; Musto, P; Boccadoro, M; Sonneveld, P; Palumbo, A.
The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo 1-gen-2011 Massi, D; Fondi, C; Nozzoli, C; Benemei, S; Lapi, F; Albarello, L; Avellini, C; Bonoldi, E; Casini, M; Cesinaro, Am; Ciceri, F; Colombetti, V; Comin, Ce; Donelli, A; Fortunato, M; Frantoni, S; Guidi, S; Messerini, L; Milone, G; Rapezzi, D; Negri, G; Patriarca, Francesca; Peccatori, Fa; Ponzoni, M; Rafaniello, P; Raimondi, R; Salomone, E; Tendas, A; Villari, L; Santucci, M; Bosi, A.
Prognostic relevance of 18-F FDG PET/TC in newly diagnosed multiple myeloma treated with up-front autologous transplantation 1-gen-2011 Zamagni, E; Patriarca, Francesca; Nanni, C; Zannetti, B; Englaro, E; Pezzi, A; Tacchetti, P; Buttignol, S; Perrone, G; Brioli, A; Pantani, L; Terragna, C; Carobolante, F; Baccarani, M; Fanin, Renato; Fanti, S; Cavo, M.
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma 1-gen-2011 Giaccone, L; Storer, B; Patriarca, Francesca; Rotta, M; Sorasio, R; Allione, B; CARNEVALE SCHIANCA, F; Festuccia, M; Brunello, L; Omedè, P; Bringhen, S; Aglietta, M; Levis, A; Mordini, N; Gallamini, A; Fanin, Renato; Massaia, M; Palumbo, A; Ciccone, G; Storb, R; Gooley, Ta; Boccadoro, M; Bruno, B.
Aspirin or enoxaparin thromboprophylaxis for newly-diagnosed multiple myeloma patients treated with lenalidomide. 1-gen-2012 Larocca, A; Cavallo, F; Bringhen, S; Di Raimondo, F; Falanga, A; Evangelista, A; Cavalli, M; Stanevsky, A; Corradini, P; Pezzati, S; Patriarca, Francesca; Cavo, M; Peccatori, J; Catalano, L; Carella, Am; Cafro, Am; Siniscalchi, A; Crippa, C; Petrucci, Mt; Yehuda, Bd; Beggiato, E; Di Toritto, Tc; Boccadoro, M; Nagler, A; Palumbo, A.
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect. 1-gen-2012 Dodero, A; Spina, F; Narni, F; Patriarca, Francesca; Cavattoni, I; Benedetti, F; Ciceri, F; Baronciani, D; Scimè, R; Pogliani, E; Rambaldi, A; Bonifazi, F; Dalto, S; Bruno, B; Corradini, P.
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 1-gen-2012 Cavo, M; Pantani, L; Petrucci, Mt; Patriarca, F; Zamagni, E; Donnarumma, D; Crippa, C; Boccadoro, M; Perrone, G; Falcone, A; Nozzoli, C; Zambello, R; Masini, L; Furlan, A; Brioli, A; Derudas, D; Ballanti, S; Dessanti, Ml; De Stefano, V; Carrella, Am; Marcatti, M; Nozza, A; Ferrara, F; Callea, V; Califano, C; Pezzi, A; Baraldi, A; Grasso, M; Musto, P; Palumbo, A
Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors. 1-gen-2012 Rinaldi, C; Savignano, C; Pasca, S; Sperotto, A; Patriarca, Francesca; Isola, Miriam; Fanin, Renato; De Angelis, V.
Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: A multicenter retrospective study based on donor availability 1-gen-2012 Patriarca, Francesca; Einsele, H; Spina, F; Bruno, B; Isola, Miriam; Nozzoli, C; Nozza, A; Sperotto, A; Morabito, F; Stuhler, G; Festuccia, M; Bosi, A; Fanin, Renato; Corradini, P.
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. 1-gen-2013 Patriarca, Francesca; Medeot, M; Isola, Miriam; Battista, Ml; Sperotto, A; Pipan, Corrado; Toffoletti, Eleonora; Dozzo, M; Michelutti, A; Gregoraci, G; Geromin, A; Cerno, M; Savignano, C; Rinaldi, C; Barbone, Fabio; Fanin, Renato
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation 1-gen-2013 Terragna, C; Renzulli, M; Remondini, D; Tagliafico, E; Di Raimondo, F; Patriarca, Francesca; Martinelli, G; Roncaglia, E; Masini, L; Tosi, P; Zamagni, E; Tacchetti, P; Ledda, A; Brioli, A; Angelucci, E; Testoni, N; Marzocchi, G; Galieni, P; Gozzetti, A; Martello, M; Dico, F; Mancuso, K; Cavo, M.
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation 1-gen-2013 Montefusco, V; Spina, F; Patriarca, Francesca; Offidani, M; Brino, B; Montanari, M; Mussetti, A; Sperotto, A; Scortechini, I; Dodero, A; Fanin, Renato; Valagussa, P; Corradini, P.
Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry. 1-gen-2013 Passera, R; Pollichieni, S; Brunello, L; Patriarca, Francesca; Bonifazi, F; Montefusco, V; Falda, M; Montanari, M; Guidi, S; Giaccone, L; Mordini, N; Carella, Am; Bavaro, P; Milone, G; Benedetti, F; Ciceri, F; Scimè, R; Benedetti, E; Castagna, L; Festuccia, M; Rambaldi, A; Bacigalupo, A; Corradini, P; Bosi, A; Boccadoro, M; Bandini, G; Fanin, Renato; Bruno, B.
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results. 1-gen-2013 Gay, F; Magarotto, V; Crippa, C; Pescosta, N; Guglielmelli, T; Cavallo, F; Pezzatti, S; Ferrari, S; Liberati, Am; Oliva, S; Patriarca, Francesca; Offidani, M; Omedé, P; Montefusco, V; Petrucci, Mt; Giuliani, N; Passera, R; Pietrantuono, G; Boccadoro, M; Corradini, P; Palumbo, A.
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD. 1-gen-2013 Olivieri, A; Cimminiello, M; Corradini, P; Mordini, N; Fedele, R; Selleri, C; Onida, F; Patriarca, Francesca; Pavone, E; Svegliati, S; Gabrielli, A; Bresciani, P; Nuccorini, R; Pascale, S; Coluzzi, S; Pane, F; Poloni, A; Olivieri, J; Leoni, P; Bacigalupo, A.
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo. 1-gen-2013 Todisco, E; Ciceri, F; Oldani, E; Boschini, C; Micò, C; Vanlint, Mt; Donnini, I; Patriarca, Francesca; Alessandrino, Pe; Bonifazi, F; Arcese, W; Barberi, W; Marenco, P; Terruzzi, E; Cortelazzo, S; Santarone, S; Proia, A; Corradini, P; Tagliaferri, E; Falcioni, S; Irrera, G; Dallanegra, L; Castagna, L; Santoro, A; Camboni, A; Sacchi, N; Bosi, A; Bacigalupo, A; Rambaldi, A.
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation. 1-gen-2014 Mariotti, J; Maura, F; Spina, F; Roncari, L; Dodero, A; Farina, L; Montefusco, V; Carniti, C; Sarina, B; Patriarca, Francesca; Rambaldi, A; Onida, F; Olivieri, A; Zallio, F; Corradini, P.
Autologous transplantation and maintenance therapy in multiple myeloma 1-gen-2014 Palumbo, A1; Cavallo, F; Gay, F; Di Raimondo, F; Ben Yehuda, D; Petrucci, Mt; Pezzatti, S; Caravita, T; Cerrato, C; Ribakovsky, E; Genuardi, M; Cafro, A; Marcatti, M; Catalano, L; Offidani, M; Carella, Am; Zamagni, E; Patriarca, Francesca; Musto, P; Evangelista, A; Ciccone, G; Omedé, P; Crippa, C; Corradini, P; Nagler, A; Boccadoro, M; Cavo, M.
Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy. 1-gen-2014 Medeot, M; Tiribelli, Mario; Patriarca, Francesca; Sperotto, A; Geromin, A; Fanin, Renato
Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death. 1-gen-2014 Moreau, P; Cavo, M; Sonneveld, P; Rosinol, L; Attal, M; Pezzi, A; Goldschmidt, H; Lahuerta, Jj; Marit, G; Palumbo, A; van der Holt, B; Bladé, J; Petrucci, Mt; Neben, K; san Miguel, J; Patriarca, Francesca; Lokhorst, H; Zamagni, E; Hulin, C; Gutierrez, N; Facon, T; Caillot, D; Benboubker, L; Harousseau, Jl; Leleu, X; Avet Loiseau, H; Mary, J. Y.
Experts' considerations on HLA-haploidentical stem cell transplantation. 1-gen-2014 Patriarca, Francesca; Luznik, L; Medeot, M; Zecca, M; Bacigalupo, A; Di Bartolomeo, P; Arcese, W; Corradini, P; Ciceri, F; Vago, L; Kanakry, Cg; Fleischhauer, K; Martelli, Mf; Bosi, A; Rambaldi, A; Cesaro, S; Russo, D; Fanin, Renato
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). 1-gen-2014 Girmenia, C; Raiola, Am; Piciocchi, A; Algarotti, A; Stanzani, M; Cudillo, L; Pecoraro, C; Guidi, S; Iori, Ap; Montante, B; Chiusolo, P; Lanino, E; Carella, Am; Zucchetti, E; Bruno, B; Irrera, G; Patriarca, Francesca; Baronciani, D; Musso, M; Prete, A; Risitano, Am; Russo, D; Mordini, N; Pastore, D; Vacca, A; Onida, F; Falcioni, S; Pisapia, G; Milone, G; Vallisa, D; Olivieri, A; Bonini, A; Castagnola, E; Sica, S; Majolino, I; Bosi, A; Busca, A; Arcese, W; Bandini, G; Bacigalupo, A; Rambaldi, A; Locasciulli, A.
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma. 1-gen-2014 Corradini, P; Vitolo, U; Rambaldi, A; Miceli, R; Patriarca, Francesca; Gallamini, A; Olivieri, A; Benedetti, F; Todeschini, G; Rossi, G; Salvi, F; Bruno, B; Baldini, L; Ferreri, A; Patti, C; Tarella, C; Pileri, S; Dodero, A.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. 1-gen-2014 Palumbo, A; Bringhen, S; Larocca, A; Rossi, D; Di Raimondo, F; Magarotto, V; Patriarca, Francesca; Levi, A; Benevolo, G; Vincelli, Id; Grasso, M; Franceschini, L; Gottardi, D; Zambello, R; Montefusco, V; Falcone, Ap; Omedé, P; Marasca, R; Morabito, F; Mina, R; Guglielmelli, T; Nozzoli, C; Passera, R; Gaidano, G; Offidani, M; Ria, R; Petrucci, Mt; Musto, P; Boccadoro, M; Cavo, M.
Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon. 1-gen-2015 Musto, P; Fraticelli, Vl; Mansueto, G; Madonna, E; Nozza, A; Andriani, A; Mussetti, A; Ballanti, S; Bongarzoni, V; Baraldi, A; Patriarca, Francesca; Vincelli, D; Falcone, A; Derudas, D; Califano, C; Zambello, R; Mele, G; Fragasso, A; Baldini, L; Storti, S.
Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma. 1-gen-2015 Ladetto, M.; Ferrero, S.; Drandi, D.; Festuccia, M.; Patriarca, F.; Mordini, N.; Cena, S.; Benedetto, R.; Guarona, G.; Ferrando, F.; Brunello, L.; Ghione, P.; Boccasavia, V.; Fanin, R.; Omedè, P.; Giaccone, L.; Palumbo, A.; Passera, R.; Boccadoro, M.; Bruno, B.
Long lasting remission after haploidentical stem cell transplant and pre-emptive donor lymphocyte infusions in a patient with primary refractory Hodgkin lymphoma 1-gen-2015 Dozzo, M.; Battista, M. L.; Medeot, M.; Sperotto, A.; Fanin, Renato; Patriarca, Francesca
Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data. 1-gen-2015 Palumbo, A; Offidani, M; Patriarca, Francesca; Petrucci, Mt; Cavo, M.
Allogeneic stem cell transplantation and novel therapies: is the treatment paradigm for younger patients with chronic lymphocytic leukemia changing? 1-gen-2015 Volpetti, S; Lucchini, E; Mazzucco, M; Perali, G; Frisoli, S; Patriarca, Francesca; Zaja, Francesco; Fanin, Renato
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. 1-gen-2015 Rambaldi, A; Grassi, A; Masciulli, A; Boschini, C; Micò, Mc; Busca, A; Bruno, B; Cavattoni, I; Santarone, S; Raimondi, R; Montanari, M; Milone, G; Chiusolo, P; Pastore, D; Guidi, S; Patriarca, Francesca; Risitano, Am; Saporiti, G; Pini, M; Terruzzi, E; Arcese, W; Marotta, G; Carella, Am; Nagler, A; Russo, D; Corradini, P; Alessandrino, Ep; Torelli, Gf; Scimè, R; Mordini, N; Oldani, E; Marfisi, Rm; Bacigalupo, A; Bosi, A.
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation. 1-gen-2015 Brioli, A; Perrone, G; Patriarca, Francesca; Pezzi, A; Nobile, F; Ballerini, F; Motta, Mr; Ronconi, S; Tacchetti, P; Catalano, L; Zannetti, Ba; Rizzi, S; Volpe, S; Zamagni, E; Liberati, Am; Mancuso, K; Boccadoro, M; Davies, Fe; Morgan, Gj; Palumbo, A; Cavo, M.
Continuous therapy versus fixed duration of therapy in patients with newly diagnosed multiple myeloma 1-gen-2015 Palumbo, Antonio; Gay, Francesca; Cavallo, Federica; Raimondo, Francesco D.; Larocca, Alessandra; Hardan, Izhar; Nagler, Arnon; Petrucci, Maria T.; Hajek, Roman; Pezzatti, Sara; Delforge, Michel; Patriarca, Francesca; Donato, Francesca; Cerrato, Chiara; Nozzoli, Chiara; Yu, Zhinuan; Boccadifuoco, Luana; Caravita, Tommaso; Benevolo, Giulia; Guglielmelli, Tommasina; Vincelli, Donatella; Jacques, Christian; Dimopoulos, Meletios A.; Ciccone, Giovannino; Musto, Pellegrino; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario
Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma. 1-gen-2015 Cavo, M; Pantani, L; Pezzi, A; Petrucci, Mt; Patriarca, Francesca; Di Raimondo, F; Marzocchi, G; Galli, M; Montefusco, V; Zamagni, E; Gamberi, B; Tacchetti, P; Brioli, A; Palumbo, A; Sonneveld, P.
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers. 1-gen-2015 Carlo Stella, C; Rcci, F.; Dalto, S. E; Mazza, R.; Malagola, M.; Patriarca, Francesca; Viviani, S.; Russo, D.; Giordano, L.; Castagna, L.; Corradini, P.; Santoro, A.
JAK-2 inhibitors and allogeneic transplant in myelofibrosis 1-gen-2015 Patriarca, Francesca; Sperotto, A; De Marchi, R; Perali, G; Cigana, C; Lazzarotto, D; Fanin, Renato
The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation 1-gen-2015 Patriarca, Francesca; Carobolante, F; Zamagni, E; Montefusco, V; Bruno, B; Englaro, E; Nanni, C; Geatti, O; Isola, Miriam; Sperotto, A; Buttignol, S; Stocchi, R; Corradini, P; Cavo, M; Fanin, Renato
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial. 1-gen-2015 Gay, F; Oliva, S.; Petrucci, M. T.; Conticello, C.; Catalano, L.; Corradini, P.; Siniscalchi, A.; Magarotto, V.; Pour, L.; Carella, A.; Malfitano, A.; Petro', D.; Evangelista, A.; Spada, S.; Pescosta, N.; Omede', P.; Campbell, P.; Liberati, A. M.; Offidani, M.; Ria, R.; Pulini, S.; Patriarca, Francesca; Hajek, R.; Spencer, A.; Boccadoro, M.; Palumbo, A.
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors. 1-gen-2015 Peccatori, J; Forcina, A; Clerici, D; Crocchiolo, R; Vago, L; Stanghellini, Mt; Noviello, M; Messina, C; Crotta, A; Assanelli, A; Marktel, S; Olek, S; Mastaglio, S; Giglio, F; Crucitti, L; Lorusso, A; Guggiari, E; Lunghi, F; Carrabba, M; Tassara, M; Battaglia, M; Ferraro, A; Carbone, Mr; Oliveira, G; Roncarolo, Mg; Rossini, S; Bernardi, M; Corti, C; Marcatti, M; Patriarca, Francesca; Zecca, M; Locatelli, F; Bordignon, C; Fleischhauer, K; Bondanza, A; Bonini, C; Ciceri, F.
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 1-gen-2016 Zamagni, E; Nanni, C; Gay, F; Pezzi, A; Patriarca, Francesca; Bellò, M; Rambaldi, I; Tacchetti, P; Hillengass, J; Gamberi, B; Pantani, L; Magarotto, V; Versari, A; Offidani, M; Zannetti, B; Carobolante, F; Balma, M; Musto, P; Rensi, M; Mancuso, K; Dimitrakopoulou Strauss, A; Chauviè, S; Rocchi, S; Fard, N; Marzocchi, G; Storto, G; Ghedini, P; Palumbo, A; Fanti, S; Cavo, M.
Mostrati risultati da 101 a 150 di 227
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile